Literature DB >> 1752981

Central pontine myelinolysis in liver transplantation.

A P Boon1, M P Carey, D H Adams, J Buckels, P McMaster.   

Abstract

Five cases of central pontine myelinolysis (CPM) were detected by neuropathological examination in a series of 50 patients coming to necropsy after liver transplantation. One patient also had extrapontine myelinolysis. In no case was the diagnosis made during life. Only two patients showed rapid rises in serum sodium concentrations. The incidence of hyponatraemia, before and after transplantation, and rapid rises in serum sodium in patients with CPM was significantly greater than in the 45 patients showing no neuropathological evidence of CPM. It is concluded that there is a high incidence of CPM after liver transplantation, that clinical diagnosis is difficult, and that there is no simple direct correlation between rapid serum sodium changes and the development of this condition. Avoidance of major electrolyte fluctuations at the time of liver transplantation is recommended but it must be emphasised that CPM may occur without any rapid rise in serum sodium concentration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752981      PMCID: PMC496628          DOI: 10.1136/jcp.44.11.909

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  42 in total

1.  Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients.

Authors:  R D ADAMS; M VICTOR; E L MANCALL
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-02

2.  Neuropathological findings in autopsies after liver transplantation.

Authors:  A P Boon; D H Adams; J A Buckels; P McMaster
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Central pontine myelinolysis and changes in serum sodium.

Authors:  W P Tormey
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

4.  Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wernicke's encephalopathy.

Authors:  P D Thompson; R F Gledhill; N P Quinn; M N Rossor; P Stanley; E N Coomes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

5.  Pontine and extrapontine myelinolysis.

Authors:  D G Wright; R Laureno; M Victor
Journal:  Brain       Date:  1979-06       Impact factor: 13.501

6.  Behavioral manifestations of central pontine myelinolysis.

Authors:  B H Price; M M Mesulam
Journal:  Arch Neurol       Date:  1987-06

7.  Pontine and extrapontine myelinolysis following rapid correction of hyponatraemia.

Authors:  R Laureno; B I Karp
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

8.  Central spinal myelinolysis.

Authors:  D Zwick; R L Friede; U Roessmann
Journal:  Neurology       Date:  1985-06       Impact factor: 9.910

9.  Mild central pontine myelinolysis: a frequently undetected syndrome.

Authors:  H W Pfister; K M Einhäupl; T Brandt
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

10.  Osmotic demyelination syndrome following correction of hyponatremia.

Authors:  R H Sterns; J E Riggs; S S Schochet
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

View more
  8 in total

Review 1.  Disseminated Nocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient.

Authors:  M Weinberger; A Eid; L Schreiber; M Shapiro; Y Ilan; E Libson; T Sacks; R Tur-Kaspa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

2.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

3.  Osmotic demyelination syndrome: plasmapheresis versus intravenous immunoglobulin?

Authors:  Kunakorn Atchaneeyasakul; Anita Tipirneni; Salomon Gloria; Andrew C Berry; Kush Shah; Dileep R Yavagal
Journal:  Intern Emerg Med       Date:  2016-04-18       Impact factor: 3.397

4.  Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study.

Authors:  Isabelle Morard; Yvan Gasche; Mark Kneteman; Christian Toso; Ariane Mentha; Glenda Meeberg; Gilles Mentha; Norman Kneteman; Emiliano Giostra
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

5.  Therapy of central pontine myelinolysis following living donor liver transplantation: Report of three cases.

Authors:  Zhong-Wei Zhang; Yan Kang; Li-Jing Deng; Chuan-Xing Luo; Yan Zhou; Xin-Sheng Xue; Dong Wang; Wan-Hong Yin
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

6.  Possible causes of central pontine myelinolysis after liver transplantation.

Authors:  Jun Yu; Shu-Sen Zheng; Ting-Bo Liang; Yan Shen; Wei-Lin Wang; Qing-Hong Ke
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

7.  Neurologic complications in adult living donor liver transplant patients: an underestimated factor?

Authors:  Fuat Hakan Saner; Julia Gensicke; Steven W M Olde Damink; Goran Pavlaković; Juergen Treckmann; Marc Dammann; Gernot M Kaiser; Georgios C Sotiropoulos; Arnold Radtke; Susanne Koeppen; Susanne Beckebaum; Vito Cicinnati; Silvio Nadalin; Massimo Malagó; Andreas Paul; Christoph E Broelsch
Journal:  J Neurol       Date:  2009-09-01       Impact factor: 4.849

8.  Recovery of locked-in syndrome following liver transplantation with calcineurin inhibitor cessation and supportive treatment.

Authors:  Walid El Moghazy; Boris Gala-Lopez; Winnie Wong; Norman Kneteman
Journal:  Am J Case Rep       Date:  2013-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.